Sort
261,768 grants matching “gene therapy”
Discovery and Development of Therapeutic Genes for CHF
$2,974,646H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2017 · HL
Lung Transplant Clinical Trial Network (LT-CTN)
$2,973,990Scott M Palmer · Duke University · U01 · FY2023 · AI
Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents
$2,973,851Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Discovery and Development of Therapeutic Genes for CHF
$2,972,180H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2013 · HL
Targeting Replication Stress and DNA Damage Response in Uterine Cancer
$2,971,802Ursula Anne Matulonis · Dana-Farber Cancer Inst · P01 · FY2024 · CA
M. D. Anderson Cancer SPORE in Genitourinary Cancers
$2,971,514University Of Texas Md Anderson Can Ctr · P50 · FY2002 · CA
Understanding Papillomavirus Virion Proteins and Vaccines
$2,971,195John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes
$2,970,192Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2012 · AI
Somatic Truncation Mutations of the Histone Methyltransferase MLL4 Alter Its Subcellular Localization in Bladder Cancer: Mechanistic Insight and Targeted Therapeutic Approach
$2,970,010Ali Shilatifard · Northwestern University At Chicago · R01 · FY2025 · CA
SPORE IN OVARIAN CANCER
$2,969,507Fox Chase Cancer Center · P50 · FY2001 · CA
Activating Autophagy to Treat Uromodulin-Associated Genetic Chronic Kidney Disease
$2,969,015Ying Maggie Chen · Washington University · R01 · FY2025 · DK
A Tolerance Approach to Xenotransplantation
$2,968,972David H Sachs · Massachusetts General Hospital · P01 · FY2012 · AI
Targets to Therapeutics in Pancreatic Cancer
$2,968,687Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2008 · CA
Basal Ganglia in Health and Disease
$2,967,142Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Neurocognitive Aging: Experience-Dependent Dynamics, Plasticity and Network Contributions
$2,966,936Peter R Rapp · National Institute On Aging · ZIA · FY2018 · AG
CANCER CENTER SUPPORT GRANT
$2,965,146Mayo Clinic Coll Of Medicine, Rochester · P30 · FY2001 · CA
The Role of the MBD2-NuRD Complex in Gamma-Globin Gene Silencing
$2,965,140Gordon D Ginder · Virginia Commonwealth University · R01 · FY2025 · DK
CANCER CENTER SUPPORT GRANT
$2,963,864Burnham Institute For Medical Research · P30 · FY2002 · CA
Creating a predictive vascular system for early development
$2,963,069Brett R Blackman · Hemoshear Therapeutics, Llc · R44 · FY2011 · HL
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$2,961,957Madhav Thambisetty · National Institute On Aging · ZIA · FY2020 · AG
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,961,826Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
HYPERTHERMIA AND PERFUSION EFFECTS IN CANCER THERAPY
$2,960,177Duke University · P01 · FY2004 · CA
Environmental Signaling in Reproduction and Pregnancy
$2,959,363Francesco Demayo · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Mechanisms of Race-Based Differences in Factor VIII Immunogenicity in Hemophilia
$2,958,699Tom Eugene Howard · Sepulveda Research Corporation · RC2 · FY2010 · HL
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,958,258Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL